← Eichor
Condition: Unresectable Nut Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Unresectable Nut Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pe
Phase 1 · 7 location(s) · National Cancer Institute (NCI) · NCT05372640Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Phase 2 · 1 location(s) · Northwestern University · NCT07050186Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplat
Phase 1/Phase 2 · 5 location(s) · National Cancer Institute (NCI) · NCT05019716
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.